Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

123.0100 USD 0.3600 0.29%

As of 20:04:05 ET on 01/30/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 123.6000 High - Low: 125.9500 - 122.9700 Primary Exchange: NYSE Arca
Volume: 195,535 52-Week Range: 80.0500 - 126.0850 Beta vs MVBBHTR: 1.0010

ETF Chart for BBH

No chart data available.
  • BBH:US 123.0100
  • 1D
  • 1M
  • 1Y
123.3700
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-01-30) 123.1099
Assets (M) (on 2015-01-30) 725.9183
Shares out (M) 5.90
Market Cap (M) 725.33
% Premium -0.08
Average 52-Week % Premium -0.0042
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) 0.00%

Performance for BBH

1-Month +6.61% 1-Year +26.97%
3-Month +6.25% 3-Year +43.23%
Year To Date +6.61% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 01/29/2015
Name Position Value % of Total
Gilead Sciences Inc 964,652 100,497,445 13.806%
Amgen Inc 535,709 83,768,816 11.508%
Celgene Corp 651,455 78,741,366 10.817%
Biogen Idec Inc 146,794 51,854,981 7.124%
Alexion Pharmaceuticals Inc 183,205 34,451,700 4.733%
BioMarin Pharmaceutical Inc 344,997 34,378,951 4.723%
Illumina Inc 171,527 34,305,400 4.713%
Regeneron Pharmaceuticals Inc 74,652 30,953,705 4.252%
Incyte Corp 378,810 30,812,405 4.233%
Vertex Pharmaceuticals Inc 269,501 30,760,844 4.226%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil